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1 rue Laurent Fries as C–H…O hydrogen bonds. Together with classical H
bonds, these appear to contribute to the stabilizationBP 163
F-67404 Illkirch Ce´dex of the ligand complex. The discovery of ligand C–H…O
hydrogen bonds directed our attention to their occur-France
rence at the protein level. They were identified based
on geometric criteria: a favorable angle and an H…O
distance smaller than a van der Waals contact (see Fig-
ure 1 and Experimental Procedures). For example, anSummary
interaction pattern similar to that of the ligand was found
for a threonine hydroxyl group and a C–H group; thisHydrogen bonds between polarized atoms play a cru-
bond could help to stabilize the conformation of the loopcial role in protein interactions and are often used in
connecting helices 6 and 7 of the antiparallel -helicaldrug design, which usually neglects the potential of
sandwich fold (Figure 2). In addition, several C–H…OC–H…O hydrogen bonds. The 1.4 A˚ resolution crystal
hydrogen bonds were found between backbone car-structure of the ligand binding domain of the retinoic
bonyl groups and C–H and C–H groups or aromaticacid receptor RARcomplexed with the retinoid SR11254
C–H groups from either protein or ligand. The followingreveals several types of C–H…O hydrogen bonds. A
sections discuss, consecutively, C–H…O hydrogenstriking example is the hydroxyl group of the ligand
bonds involving hydroxyl groups, aromatic C–H groups,that acts as an H bond donor and acceptor, leading
and C–H or C–H groups. The functional occurrenceto a synergy between classical and C–H…O hydrogen
of C–H…O hydrogen bonds in intraprotein and protein-bonds. This interaction introduces both specificity and
ligand interactions suggests a hitherto unused potentialaffinity within the hydrophobic ligand pocket. The simi-
for rational drug design.larity of intraprotein and protein-ligand C–H…O interac-
tions suggests that such bonds should be considered
Results and Discussionin rational drug design approaches.
Structure Determination and Description
Introduction of the SR11254 Complex
The crystal structure of the hRAR LBD bound to the
Hydrogen bonds play a crucial role in macromolecular RAR-selective retinoid agonist SR11254 has been de-
recognition, folding, and stability. They involve mainly termined at 1.38 A˚ resolution (Table 1). The known
polarized atoms such as oxygen and nitrogen, and par- hRAR LBD/CD564 structure refined at 1.30 A˚ resolution
ticularly those of the main chain peptide group and polar [11] has been used as a starting model for molecular
side chain groups in proteins. C–H…O hydrogen bonds replacement. Structure refinement has been performed
are a typical example of weak hydrogen bonds involving with the programs CNS [14] and SHELXL [16] including
less polar groups [1, 2]. C–H…O hydrogen bonds are anisotropic B factor refinement and occupancy refine-
well characterized for organic compounds and have ment of multiple conformations (see Experimental Pro-
been described quite often for nucleic acids, where they cedures), leading to good Rfree/Rcryst values (15.8%/can be determinants for base-pairing specificity [2], but 13.0%) and geometries (Table 1). The overall structure
they are still less well documented for proteins. C–H…O is very similar to that of other hRAR LBD agonist ligand
hydrogen bonds within  sheets have been reported complexes (rmsd  0.15 A˚ on C atoms) [11, 13].
[3–5], as well as between carbonyl groups and the acidic SR11254 [16–18] is an RAR-selective agonist that car-
C–H groups (C1–H or C2–H) of histidine side chains ries an oxime moiety attached at the bridge linking the
[2, 4, 6]. In this paper, we discuss the structural role of 5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl
different types of C–H…O hydrogen bonds revealed in and 2-naphthoic acid moieties (Figure 3A). The electron
the crystal structure of a ligand complex of the human density indicates two orientations of the oxime moiety
retinoic acid receptor hRAR. The nuclear receptor RAR (Figure 3A) that correspond to the Z and E isomers of
is an important pharmaceutical target, since it is a li- SR11254, respectively (Figure 3C). The similar occu-
gand-dependent transcription regulator [7, 8] implicated pancies of these isomers (46% and 54%, respectively)
in cell differentiation, cancer, and various skin diseases suggest similar affinities, although data have not been
([9–11] and references therein). Therefore, the crystal measured for the individual isomers [18]. Despite the
structures of several RAR ligand complexes have been presence of two ligand isomers, none of the neighboring
solved previously, addressing the questions of ligand
Key words: C–H…O hydrogen bond; protein stability; drug design;
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Table 1. Statistics for the Data Collection and Structure
Refinement of the hRAR LBD/SR11254 Complex
Resolution (A˚) 20–1.38
Reflections observed 291,021
Unique reflections 59,004
Multiplicity 4.9 (4.0)
Highest resolution shell (A˚) 1.41–1.38
Completeness (%) 99.8 (99.8)
Rsym (I) (%) 4.2 (36.2)
I/ (I) 36.0 (3.3)Figure 1. Definition of Distances and Angles of a C–H…O Contact
Refinement statisticsThe geometric criteria chosen for a C–H…O hydrogen bond are:
Residualshydrogen bond distance dH  2.7–2.8 A˚ (corresponds to the sum
Rfree (%) (5% of reflections) 15.8of van der Waals radii); C–O…H angle 	 
 110 (which is more
Rcryst (%) 13.0restrictive than the commonly used criterion 	  90–180; theoreti-
Goodness of fit (SHELX) 1.8cally, 	 is close to 120 because of the geometry of the electron
Restrained goodness of fit 1.5lone pairs of the oxygen atom); C–H…O angle   90; elevation
Refinement resolution (A˚) 6–1.38angle   45 (calculated from the relationship sin  sin	·sin, with
Observations 58,146 dihedral angle H…O–C–C/N; ideally, || is expected to be close
Parameters 21,188to 0; representation adapted from [2, 3]). The hydrogen bond donor-
Restraints 26,389acceptor distance is dCO (not shown).
Observations/parameters 2.7
Model (anisotropic)
Protein atoms 2,094
residues are disordered. As in other ligand complexes Water molecules
Fully occupied 237[11–13, 19], the carboxylate moiety of the retinoid is
Partly occupied 94anchored by a network of hydrogen bonds with Arg 278,
Ligand atoms 29Ser 289, a water molecule, and the carbonyl backbone
Detergent atoms 35group of Leu 233. The hydroxyl group moiety of the
Double conformations 24
oxime group provides isotype selectivity through a hy- Bavga (A˚2) protein atoms 23.8
drogen bond with the sulfur atom of the RAR-specific Bavga (A˚2) water molecules 36.7
Bavga (A˚2) ligand atoms 17.1Met 272 (Figure 3A), confirming a previous modeling
Bavga (A˚2) detergent atoms 39.2study [12]. This interaction is the molecular basis for the
StereochemistryRAR selectivity of other ligands that carry hydroxyl
Rmsd bond lengthb (A˚) 0.013groups as well [11–13].
Rmsd bond angleb () 2.387
Rmsd bond angle distance (A˚) 0.031
C–H…O Hydrogen Bonds of the Ligand Rmsd improper anglesb () 2.071
Rmsd dihedral anglesb () 26.381Hydroxyl Group
Overall G factorc 0.13In addition to the interactions described above, the hy-
Ramachandran plot, regionsdroxyl group of SR11254 exhibits two close contacts to
Most favored (%) 95.1Met 272 and Ile 275 as revealed by the electron density
Additionally allowed (%) 4.9
Values in parentheses correspond to the highest resolution shell.
Rsym (I)  hkl i | Ihkl,i   Ihkl  | / hkl i |Ihkl,i|, with  Ihkl  the
mean intensity of the multiple Ihkl,i observations for symmetry-related
reflections. The high-resolution limit is set by an I/I 
 3 criterion.
Rcryst  hkl | Fo  Fc | / hkl |Fo|; Rfree  hklT | Fo  Fc | / hklT |Fo|; the
test set T includes 5% of the data [36]. Rcryst values are indicated
for the model before including the test set T in the final refinement
cycle.
a Bavg isotropic B factor calculated from the anisotropic U matrix.
b Target stereochemistry from Engh and Huber [37].
c G factors should be above 0.5 as reported by PROCHECK [32].
map (Figure 3A). The distances and geometries dis-
cussed in the following suggest that these contacts cor-
respond to C–H…O hydrogen bonds between an oxygen
atom of a hydroxyl group and hydrogens attached to
aliphatic carbon atoms. The hydroxyl group of the Z
isomer exhibits close contacts to Met 272 (Figure 3A;
2.95 A˚ with the sulfur atom and 2.86 A˚ with the C atom),
whereas the E isomer has contacts to both Met 272
(3.48 A˚ to the sulfur atom) and Ile 275 (3.19 A˚ to the C1
methyl group). The contacts between the hydroxyl groupFigure 2. Overall Structure of the hRAR LBD/SR11254 Complex
of the SR11254 isomers and the Met 272 sulfur atomThe ligand is represented by orange van der Waals spheres; helices
are classical hydrogen bonds, where the interaction of(shown as tubes) and the  sheet (shown as arrows) are numbered
from the N to C terminus. the Z isomer is particularly strong with respect to the
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Figure 3. Details of the Crystal Structure of the hRAR LBD/SR11254 Complex
The figure shows the analogy of hydroxyl group interaction patterns that lead to a synergy of classical and C–H…O hydrogen bonds: role of
the hydroxyl groups of the ligand (A) and Thr 308 (B); stereo representations (A and B); schematic representation (C). The A-weighted
and F21/4-sharpened 2mFoDFc electron density map (see Experimental Procedures; colored in blue) at 1.38 A˚ resolution is contoured at
1.0  (for all figures; values indicate distances dCO or dNO between heavy atom positions; geometry details are given in the text). It reveals the
presence of a mixture of Z and E isomers of the RAR-selective retinoid SR11254 (represented in green and yellow, respectively). The hydroxyl
moiety of the ligand’s oxime group is activated by the hydrogen bond to the Met 272 sulfur atom, and acts as a C–H…O hydrogen bond
acceptor for the methyl groups of Met 272 (for the Z isomer) and Ile 275 (for the E isomer). Similarly, the hydroxyl group of Thr 308 is H bonded
to a backbone carbonyl group and forms a C–H…O hydrogen bond with the C–H atom of His 300. The important oxygen atoms are colored
red; helix 5 and the loop between helices 6 and 7 are indicated.
range of typical distances between hydroxyl and thio- exhibits multiple conformations. Moreover, the oxime
group is particularly stable according to the low temper-ether groups according to the Cambridge Structural Da-
tabase [20] (3.2–3.5 A˚) and the Protein Data Bank ature factors (range of 15–17 A˚2 ; compare to the average
B factors: ligand 17 A˚2 , protein 24 A˚2 ; Table 1).(2.9–3.5 A˚) [21]. In contrast, the contacts of the oxime
oxygen atom of the Z and E isomers with the methyl These data suggest that the hydroxyl moiety of the
SR11254 isomers acts simultaneously as a hydrogengroups of Met 272 and Ile 275, respectively, are unusual,
since they are closer than a van der Waals contact (dCO bond donor and acceptor, leading to a synergy between
C–H…O hydrogen bonds and the classical O–H…S hy-3.75 A˚, dH  2.7–2.8 A˚; see Figure 1 for a definition of
the distances and angles describing the geometry of a drogen bonds (Figure 3C). In fact, the oxygen atom may
be activated by the hydrogen bond to the sulfur, makingC–H…O contact and the criteria chosen for a C–H…O
hydrogen bond). The geometry is in favor of a C–H…O it a better acceptor. Moreover, the C–H…O hydrogen
bond satisfies the hydrogen bond potential of the oxy-interaction (dCO  2.86 A˚, dH  2.29 A˚, 	  170 for the
Z isomer, dCO  3.19 A˚, dH  2.60 A˚, 	  146 for the E gen electron lone pair. The synergy is consistent with
the excellent binding affinity of SR11254 (Kd  3–5 nMisomer; Figure 3A). Rotation of the methyl group for
which the hydrogen atoms have been introduced as for RAR) [17, 18, 22], which is at least one order of
magnitude better than that of other RAR-selective li-“riding hydrogens” using the program SHELXL [15]
would lead to dH values still below simple van der Waals gands [11, 18, 22, 23]. For example, the chemically close
retinoid BMS184394 (oxime group replaced by a hy-contacts (range of 2.15–2.70 A˚ and 2.24–2.80 A˚ for the
Z and E isomers, respectively). Note that Met 272 is not droxyl group; Kd 75 nM) does not exhibit any additional
C–H…O hydrogen bonds in the RAR complex [11], theconformationally restrained by the neighboring residues
(as revealed by its different conformation in complexes interaction of an aromatic C–H group with a backbone
carbonyl group being common to these retinoid com-with non-RAR-selective ligands that provide no H bond
to Met 272 [11]) and that none of the adjacent residues plexes (see below).
Structure
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C–H…O Hydrogen Bond Analogy of the Thr 308 18, respectively), whereas it may be weaker in the
BMS181156 complex (dH  2.56 A˚, 	  121,   42)Hydroxyl Group
Different types of C–H…O hydrogen bonds were found due to the different conformation of the ligand’s 2-ethen-
ylbenzoic acid moiety [11]. Note that the above-men-that involve either aromatic or aliphatic H bond donors
and keto or alcohol groups. The case of Thr 308 is partic- tioned retinoid BMS184394, which is closely related to
SR11254, exhibits the same type of interaction.ularly remarkable since it exhibits an interaction pattern
analogous to that of the hydroxyl group of SR11254
described above (Figure 3). The hydroxyl group of Thr C–H…O Hydrogen Bonds in the  Sheet
308 acts simultaneously as a hydrogen bond donor and and in Helix-Loop Transitions
acceptor. It exhibits a C–H…O hydrogen bond to the Several C–H…O hydrogen bonds were found in the anti-
C–H group of His 300 (dCO  3.01 A˚, dH  2.22 A˚, 	  parallel  sheet of RAR (Figure 2), where four backbone
146; Figures 3B and 3C) and a classical hydrogen bond carbonyl groups exhibit bifurcated hydrogen bonds to
to the carbonyl backbone group of Gly 305 (dCO 2.64 A˚, both backbone amino and C–H groups of adjacent
CO…O angle 140; the CO…O angle rather than the residues (Figure 5A). The staggered arrangement of the
CO…H angle was measured since hydrogen atoms of carbonyl group with respect to the two H bond donor
hydroxyl groups were not included in the refinement; groups favors a synergy between classical and C–H…O
see Experimental Procedures). The Gly 305 carbonyl hydrogen bonds. The geometry of the C–H…O hydrogen
group is in turn H bonded to the backbone amino group bonds (dCO  3.2–3.4 A˚, dH  2.36–2.56 A˚, 	  130–147)of Thr 308 (dCO  3.01 A˚, dH  2.17 A˚, 	  133, a classical is similar to that of the antiparallel  sheets of other
intrahelical hydrogen bond). Thus, the oxygen atoms of proteins [3, 5, 26]. All elevation angles meet the C–H…O
both the Gly 305 carbonyl group and the Thr 308 hy- hydrogen bond criteria (Figure 1), where only one is
droxyl group satisfy their hydrogen bonding potential. close to ideal (4) and the others are notably higher
The C–H atom is particularly well suited for a C–H…O (22–28). The latter values appear to still be favorable,
hydrogen bond due to its slightly acidic character, being since they compare well with those found for the classi-
adjacent to two electron-withdrawing groups (backbone cal hydrogen bonds stabilizing  helices (see below).
carbonyl and amino groups); consistently, ab initio Several C–H…O hydrogen bonds were found in loops,
quantum calculations show the C–H group to be a or in structural elements that correspond to transitions
potent proton donor [24, 25]. This also explains the oc- from helices to loops (as for the above mentioned
currence of C–H…O hydrogen bonds in the  sheet (see C–H…O hydrogen bond of Thr 308 within the loop con-
below). necting helices 6 and 7; Figure 2). Figures 5B and 5C
illustrate two cases where hydrogen bond donors are
found in a 1,4 position (a backbone amino group and aAromatic C–H…O Hydrogen Bonds of Trp 227
side chain C–H group, respectively), satisfying bothand the Drug
electron lone pairs of a backbone carbonyl oxygen atom:The crystal structure of the SR11254 complex provides
the Ser 194 carbonyl interacts with both the backboneseveral cases of C–H…O hydrogen bonds with aromatic
amino group of Gln 198 (dNO  2.91 A˚, dH  2.07 A˚, 	 C–H groups, exemplified by two cases: the side chain
155; Figure 5B) and the C–H group of its side chainof Trp 227 and the 2-naphthoic acid moiety of SR11254
(dCO  3.13 A˚, dH  2.28 A˚, 	  143). In the same way,(Figure 4). The case of Trp 227 is particularly interesting
the backbone carbonyl group of Tyr 374 acts as a doublebecause two C–H…O hydrogen bonds are provided by
hydrogen bond acceptor for the backbone amino groupthe same residue to a backbone carbonyl group (Figure
of Arg 378 (dNO  2.97 A˚, dH  2.14 A˚, 	  156; Figure4A). The C3–H group (dCO  3.38 A˚, dH  2.45 A˚, 	  5C) and its C–H group (dCO  3.17 A˚, dH  2.50 A˚, 	 159) and the C–H group (dCO  3.41 A˚, dH  2.58 A˚, 137). These C–H…O hydrogen bonds may contribute
	  135) of Trp 227 are almost coplanar with the car-
to the stabilization of the C-terminal part of helix H1 andbonyl group of Ala 302 (  8 and 16, respectively).
the N-terminal part of H10, respectively (Figure 2). TheNote that the electron lone pairs of the carbonyl group
relatively high elevation angle  (37 in both cases) sug-would remain unsatisfied in the absence of this interac-
gests weak C–H…O hydrogen bonds. Note, however,tion. Moreover, the side chain of Trp 227 exhibits no
that the values found for the classical intrahelical Hconformational restriction by adjacent residues, its N1
bonds are also quite high (see [3]; in RAR,  is aroundatom being in contact with the first hydration shell (Fig-
20–30) compared to the ideal value (0).ure 4A).
Figure 4B illustrates a C–H…O hydrogen bond involv-
ing an aromatic moiety of the ligand: the carbonyl back- Significance of C–H…O Hydrogen Bonds
for Drug Designbone group of Leu 271 interacts with the backbone
amino group of Ile 275 (H bond within helix H5) and with C–H…O hydrogen bonds described in this paper involve
slightly acidic C–H groups (C–H’s and aromatic C–H’s),a C–H group of the 2-naphthoic acid moiety of SR11254
(dH  2.54 A˚, 	  128,   17; the carbonyl oxygen is but also less activated aliphatic C–H groups (methyl
groups of Met 272, Ile 275, and C–H groups of Gln 198coplanar with the aromatic ring). The detection of this
additional H bond prompted us to check its presence and Arg 378). They were found to interact with oxygen
atoms of keto and, unexpectedly, alcohol groups of ei-in other previously published ligand complexes [11, 13].
According to the geometry, it seems to be also quite ther the drug or the protein, where the drug exhibits two
interactions of this type. The present data show that astrong in the BMS270394 and CD564 complexes (dH 
2.35 A˚ and 2.46 A˚, 	  138 and 130, and   9 and specific interaction pattern can favor the occurrence of
C–H…O Hydrogen Bonds in an RAR Ligand Complex
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Figure 4. Stereo Views of C–H…O Hydrogen Bonds Involving Aromatic C–H Groups
(A) Both the C3–H and C–H atoms of Trp 227 (helix H3) interact with the backbone carbonyl group of Ala 302 (loop between helices H6 and
H7). The tryptophan side chain is not conformationally constrained being in direct contact with the first hydration shell (a water molecule is
depicted on the left).
(B) Similarly, the backbone carbonyl group of Leu 271 (helix 5) exhibits a hydrogen bond to a C–H atom of the 2-naphthoic acid moiety of
the ligand SR11254 (colored in yellow; this interaction is found for both isomers).
C–H…O hydrogen bonds where a hydroxyl group acts elevation angles were observed for other retinoid com-
plexes [11, 13] and involve contacts between ligandas an acceptor. In both cases described in this paper,
the hydroxyl group is activated by an H bond to another carbonyl groups and the slightly acidic C–H groups of
phenylalanine residues.polar atom (sulfur of Met 272 and carbonyl group of Gly
305, respectively), leading to a synergy of classical and Considering the weak energy contribution of individ-
ual C–H…O hydrogen bonds (1–2 kcal mol1 comparedC–H…O hydrogen bonds. In the  sheet, this synergy
is favored by the staggered arrangement of the carbonyl to 2–10 kcal mol1 for classical hydrogen bonds [2, 24,
25]), their role for drug design may appear questionable.group with respect to the two H bond donor groups.
In contrast to the isotropic van der Waals contacts, However, the analogy between the observed protein-
ligand and intraprotein interactions supports the func-the directionality of H bonds is known to be important
for molecular recognition [2, 27]. In that respect, it is tional importance of the C–H…O hydrogen bond. At the
level of the protein, the occurrence of C–H…O hydrogenremarkable that the elevation angle  is quite often
higher than ideally expected, although the geometry of bonds has a cooperative effect on global protein stabil-
ity, in particular the conformational stabilization of sidethe C–H…O hydrogen bonds described here is within
the chosen criteria (see Figure 1). Relatively high  values chains,  sheets, or loops (Figures 3B, 4A, and 5). In the
case of the interaction of the Z and E isomers of SR11254occur, for instance, in the cases of the C–H groups of
Arg 378 and Gln 198 (Figures 5B and 5C). However, with Met 272 and Ile 275, the present high-resolution
data suggest that C–H…O hydrogen bonds contributesimilar values are also observed in the case of classical
N–H…O hydrogen bonds that stabilize the architecture in a significant way to the binding affinity of the ligand.
For SR11254, an energy decrease by 1–2 kcal mol1of  helices, suggesting that this criterion is not a de-
termining factor. Similar C–H…O interactions with high would lead to an increase in the affinity by one order of
Structure
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Figure 5. C–H…O Hydrogen Bonds in the  Sheet and in Helix-Loop Transitions
(A) Bifurcated hydrogen bonds in the  sheet (located between helices H5 and H6) of RAR: several carbonyl backbone groups exhibit C–H…O
hydrogen bonds (green dotted lines) in addition to the classical H bonds (yellow dotted lines). The electron density map and the corresponding
model of the side chains have been omitted for clarity. Color code for atoms: oxygen, red; hydrogen, yellow; nitrogen, blue; carbon, gray.
(B and C) Hydrogen bond donors in a 1,4 position satisfy both electron lone pairs of a backbone carbonyl oxygen atom: by a classical
intrahelical H bond with a backbone amino group and by a C–H…O hydrogen bond with side chain C–H groups of Gln 198 (B) and Arg 378
(C), respectively. These interactions are found at the C- and N-terminal parts of helices H1 and H10, respectively.
magnitude, just as expected from the comparison with may turn out to be the driving force for the introduction
of ligand selectivity. Such C–H…O hydrogen bonds areother retinoids. This may be due in part to the hydropho-
bic pocket where additional C–H…O hydrogen bonds likely to play a significant role in many other ligand com-
C–H…O Hydrogen Bonds in an RAR Ligand Complex
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was solved by molecular replacement using the 1.3 A˚ resolutionplexes and could be used for rational drug design ap-
structure of the CD564 complex as a starting model (PDB codeproaches.
1FCY) [11]. An initial rigid body refinement with the program CNS-
0.4a [14] was followed by a simulated annealing (T 500 K), followed
Biological Implications by an individual temperature factor refinement; the calculated elec-
tron density maps (A-weighted 2mFoDFc and mFoFc maps [31])
revealed that both Z and E isomers of SR11254 were bound, differingHydrogen bonds play a pivotal role in protein interac-
by the orientation of the oxime moiety (see Figures 3A and 3C).tions, including folding and molecular recognition. They
The isomers were fitted to the electron density and subsequentlycan be used for drug design in order to introduce spe-
included in the refinement. When the refinement converged to values
cific interactions with a target, but usually only hydrogen of Rfree/Rcryst 21.4%/19.9%, it was completed with the program
bonds between polar atoms are considered. Here we SHELXL (SHELX-97) [15], keeping the Rfree reference set (5% ran-
provide evidence for the importance of C–H…O hydro- domly chosen reflections). A first cycle of least square minimiza-
tions/anisotropic B factor refinement reduced the Rfree value bygen bonds for specific ligand-protein interactions and
2.4%. The occupancy of the Z and E isomers of SR11254 wasfor protein conformational stability. We have solved the
refined with SHELXL to 46% and 54%, respectively: to allow differentcrystal structure of the ligand binding domain of the
geometries of the ligand, the oxime moiety and the adjacent carbon
retinoic acid receptor RAR complexed with the RAR- atoms were refined as two independent copies, with the constraint
selective retinoid SR11254 at high resolution (1.4 A˚). of a total occupancy of 1; geometric restraints for the ligand were
Several types of C–H…O hydrogen bonds were found, applied. Hydrogens could be detected in sharpened A-weighted
2mFoDFc maps (Fourier coefficients are weighted by F21/4,involving C–H, aromatic C–H groups, and less-acti-
where F2 is the mean reflection intensity in a given resolutionvated aliphatic C–H groups. The similarity of intraprotein
shell) and were added as “riding” hydrogen atoms to the modeland protein-ligand C–H…O interactions suggests a
associated with all protein, ligand, and detergent atoms, except for
functional role for these bonds. For example, the hy- hydroxyl groups, in order to avoid problems from any ambiguous
droxyl group of the ligand acts as an H bond donor and hydrogen bond networks [11]. The hydrogen atom of the ligand
acceptor, leading to a synergy between classical and oxime moiety was excluded in all refinements in order to avoid bias
in electron density maps. Final Rfree/Rcryst values are 15.8%/13.0%C–H…O hydrogen bonds; a similar interaction pattern
(6–1.38 A˚, no  cutoff; Table 1). According to PROCHECK [32], theis found for a threonine hydroxyl group. Moreover, the
refined models are better than the average and show no Ramachan-ligand exhibits an aromatic C–H/carbonyl group interac-
dran plot outlier. Backbone superposition of the complexes was
tion, as a tryptophan residue does. The data suggest achieved using the LSQ option in the program O [33]. The pictures
inclusion of such hydrogen bonds in drug design, espe- of Figures 2–5 were generated with Setor [34].
cially when specific interactions are difficult to introduce
in a hydrophobic environment such as the retinoic acid Identification of C–H…O Hydrogen Bonds
Two consecutive criteria were used to identify C–H…O hydrogenreceptor ligand pocket.
bonds: first, a statistical analysis of close contacts (cutoff 3.4 A˚)
between aliphatic and aromatic carbons and all types of polar atomsExperimental Procedures
(oxygens classified according to their affiliation: carbonyl, hydroxyl,
ether groups, and water molecules; nitrogens and sulfurs). ExcludedProtein Purification, Crystallization, and Data Collection
were residues with multiple conformations and those separated byPurification and crystallization of the hRAR ligand binding domain
less than three amino acids in sequence. Second, a visual inspectioncomplexed with the retinoid SR11254 (6-[hydroxyimino-(5,5,8,8-tet-
of each close contact, checking the following hydrogen bond criteriaramethyl-5,6,7,8-tetrahydro-naphthalen-2-yl)-methyl]-naphthalene-
(see Figure 1): H–O distance smaller than the van der Waals contact2-carboxylic acid) follows the previously published procedure for
(sum of van der Waals radii of oxygen and carbon-bonded hydrogen)other retinoid complexes [11, 28]. The histidine-tagged hRAR LBD
dH  2.7–2.8 A˚, C–O…H angle 	
 110 (which is more restrictive than(domain E, residues 178–423) was overproduced using a pET-15b
the 	 90 criterion usually admitted [2, 3]; see also the discussion ofexpression vector and the E. coli BL21(DE3) strain from Novagen.
hydrogen bond criteria in [35]; theoretically, 	 should be close toThe protein was purified by nickel chelate affinity chromatography
120 due to the geometry of the oxygen electron lone pair). C–H…Oand gel filtration; the N-terminal histidine tag was kept for crystalliza-
contacts for which the oxygen atom has more than two possible Htion, which was carried out with the hanging drop vapor diffusion
bond donors were rejected; for example, one out of five C–H…Omethod at 17C. The 0.5 ml reservoir contained 0.1 M PIPES (pH
contacts in the  sheet was rejected because of an alternative hydro-7.0) and 0.3 M NaOAc. The drops were formed by mixing 5 l protein
gen bond to a water molecule.solution (3.7 mg ml1) with 5 l precipitant solution from the reser-
voir. Crystals were stabilized by gradually adding a 1.3 M NaOAc
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Structure Determination and Refinement
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